Transactions in the US and China may also be affected, resulting in lost deals worth about $700 billion in the two countries through 2020.

The company’s Baddi plant has received the German drug regulator’s approval and expects to get approval of three of its drugs by September ...

Vaccine maker Panacea Biotec has agreed to buy 19.9% in US-based PharmAthene for $13.1 mn.

Vaccine manufacturer Panacea Biotec on Wednesday said it has entered into a strategic alliance with US-based PharmAthene and will invest 13...